Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TuHURA Biosciences (HURA)
NASDAQ:HURA
RESEARCH TOOLSreports
Holding HURA?
Track your performance easily
HURA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.85 - $14.60
Previous Close$4.15
Volume133.57K
Average Volume (3M)299.62K
Market Cap
$175.48M
Enterprise Value$172.46M
Total Cash (Recent Filing)$3.02M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.48
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-75.23
Shares Outstanding42,284,524
10 Day Avg. Volume412,002
30 Day Avg. Volume299,617
Standard Deviation0.32
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)138.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-25.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-23.07
Forecast
1Y Price Target
$13.00Price Target Upside192.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
TuHURA Biosciences News
PremiumCompany Announcements
TuHURA Biosciences to Acquire Kineta, Inc. in 2025
PremiumCompany Announcements
TuHURA Biosciences Advances in Cancer Immunotherapy Innovations
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HURA FAQ
What was TuHURA Biosciences’s price range in the past 12 months?
TuHURA Biosciences lowest stock price was $2.85 and its highest was $14.60 in the past 12 months.
What is TuHURA Biosciences’s market cap?
Currently, no data Available
When is TuHURA Biosciences’s upcoming earnings report date?
TuHURA Biosciences’s upcoming earnings report date is Feb 18, 2025 which is in 55 days.
How were TuHURA Biosciences’s earnings last quarter?
Currently, no data Available
Is TuHURA Biosciences overvalued?
According to Wall Street analysts TuHURA Biosciences’s price is currently Undervalued.
Does TuHURA Biosciences pay dividends?
TuHURA Biosciences does not currently pay dividends.
What is TuHURA Biosciences’s EPS estimate?
TuHURA Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TuHURA Biosciences have?
TuHURA Biosciences has 42,284,523 shares outstanding.
What happened to TuHURA Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TuHURA Biosciences?
Currently, no hedge funds are holding shares in HURA
---
TuHURA Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (192.13% Upside)
$13.00 (192.13% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 56.2%
Last 30 Days ▲ 56.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.66%
12-Months-Change
Fundamentals
Return on Equity
-370.77%
Trailing 12-Months
Asset Growth
55.87%
Trailing 12-Months
Company Description
TuHURA Biosciences
DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
---
HURA Stock 12 Month Forecast
Average Price Target
$13.00
▲(192.13% Upside)
Technical Analysis
Best Analysts Covering HURA
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-46.75%
initiated a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -46.75% per trade.
---